Novo Nordisk A/S – Share repurchase programme
Novo Nordisk A/S – Share repurchase programmeBagsværd, Denmark, 21 October 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Rules”). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 1 February 2019.Under the programme initiated 9 August 2019, Novo Nordisk will repurchase B shares for an amount up to DKK 2.6 billion in the period from 9 August 2019 to 30 October 2019.Since the announcement as of 14 October 2019, the following transactions have been made:The details for each transaction made under the share repurchase programme are published on novonordisk.com.With the transactions stated above, Novo Nordisk owns a total of 37,044,994 B shares of DKK 0.20, corresponding to 1.5% of the share capital, as treasury shares. The total amount of A and B shares in the company is 2,400,000,000 including treasury shares.
Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 1 February 2019. As of 18 October, Novo Nordisk has since 1 February 2019 repurchased a total of 29,885,962 B shares at an average share price of DKK 331.26 per B share equal to a transaction value of DKK 9,900,167,631.Further informationCompany announcement no. 59 / 2019AttachmentCA191021_Safe_Harbour